ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, it is still a matter of contention if BCR-ABL transcript-level data observed in the defined time points may be significantly predictive for the long-term outcome of CML patients treated with IM first line and might improve or even replace the prognostic significance of cytogenetic data 10,11.